Brazil Opens Route for Emergency Approval of COVID-19 Vaccines

Health Minister Eduardo Pazuello told lawmakers on Wednesday that Brazil would begin receiving about 15 million doses of the AstraZeneca vaccine between January and February, with 100 million doses arriving by the middle of the year.

RIO DE JANEIRO, BRAZIL - Brazil’s health regulator ANVISA said on Wednesday, December 2nd, it was open to approving COVID-19 vaccines for emergency use and outlined the requirements for companies looking to do so.

ANVISA said authorizations would be analyzed on a case-by-case basis and that to be considered the vaccine must be in late-stage trials in Brazil. It said no requests had been received so far.

AstraZeneca, Johnson & Johnson, Pfizer and Sinovac currently have vaccines in Phase III trials in Brazil.

The regulator said producers should still seek the usual registrations for their vaccines . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?